92
R.K. Sharma et al. / Inorganica Chimica Acta 411 (2014) 90–96
d: 2.28 (s, Me); 6.76 (s, ring proton). 13C{1H} NMR (CDCl3,) d: 23.6
(Me); 116.6 (CH-5); 166.8 (C-4,6); 171.6 (C-2) (ring carbons).
77Se{1H} NMR (CDCl3) d: 342. 199Hg{1H} NMR (CDCl3,) d: ꢀ1521.
in situ by reduction of Se–Se bond in [{SeC4H(R-4,6)2N2}2] in tolu-
ene–methanol by a methanolic solution of NaBH4 under an argon
atmosphere) gave selenolate complexes, [Cd{SeC4H(4,6-R)2N2}2
(tmeda)] (Eq. (1)). Similar reaction with HgCl2.tmeda gave
[Hg(SeC4H3N2)2(tmeda)] and [Hg{SeC4H(Me-4,6)2N2}2] depending
on the substituent in the pyrimidyl ring. The latter and its cad-
mium analog can be prepared readily by the reaction between
MCl2 (M = Cd or Hg) and NaSe-C4H(Me-4,6)N2 (Eq. (2)). Redistribu-
tion reaction between [M{Se-C4H(Me-4,6)N2}2] and MCl2 followed
by treatment with tmeda afforded heteroleptic complexes,
[MCl{SeC4H(Me-4,6)2N2}(tmeda)] (Eq. (3)).
2.2.5. Preparation of [Cd{SeC4H(Me-4,6)2N2}2] (5)
To a freshly prepared NaSeC4H(Me-4,6)2N2 [from toluene–
methanol solution of [{SeC4H3(Me-4,6)2N2}2] (300 mg, 0.81 mmol)
and NaBH4 (66 mg, 1.74 mmol) in methanol], CdCl2 (145 mg,
0.79 mmol) was added with stirring which continued for 2 h at
room temperature. The solvents were evaporated under vacuum.
The residue was thoroughly washed with water followed by ace-
tone and dried under vacuum to yield yellow powder (318 mg,
83%), m.p. 200 °C. Anal. Calc. for C12H14CdN4Se2: C, 29.74; H,
2.91%. Found: C, 29.06; H, 2.93%.
½CdCl2ðtmedaÞꢂ þ 2 NaSeC4HðR-4; 6ÞN2
Â
Ã
CdfSeC4HðR-4; 6Þ2N2g2ðtmedaÞ þ 2NaCl
ð1Þ
ð2Þ
ð3Þ
!
where R = H, Me
2.2.6. Preparation of [CdCl{SeC4H(Me-4,6)2N2}(tmeda)] (6)
½MCl2=HgCl2ðtmedaÞꢂ þ 2 NaSeC4HðMe-4; 6Þ2N2
To a suspension of 5 (250 mg, 0.52 mmol) in toluene–methanol
mixture, solid CdCl2 (95 mg, 0.52 mmol) was added and after stir-
ring for 3 h at room temperature, tmeda in excess was added in the
solution and stirred for 30 min. The solvent was evaporated in vac-
uum and the residue was extracted from dichloromethane and
recrystallized similar to 1 (357 mg, 77%), m.p. 148 °C. Anal. Calc.
for C12H23CdClN4Se: C, 32.01; H, 5.15%. Found: C, 32.43; H, 4.89%.
UV–Vis kmax (CH2Cl2): 285 nm. 1H NMR (CDCl3) d: 2.35 (s, Me);
2.48 (s, NMe2); 2.63 (s, NCH2ꢀ); 6.63 (ring proton). 13C{1H} NMR
(CDCl3) d: 23.5 (Me); 47.1 (NMe2); 56.6 (NCH2); 114.8 (CH-5);
166.2 (C-4,6); 175.8 (C-2) (ring carbons). 77Se{1H} NMR (CDCl3)
d: 198. 113Cd{1H} NMR (CDCl3) d: 342.
Â
Ã
MfSeC4HðMe-4; 6Þ2N2g2 þ 2NaCl
!
where M = Cd, Hg
Â
Ã
MfSeC4HðMe-4; 6Þ2N2g2 þ MCl2 þ tmeda
Â
Ã
2
MClfSeC4HðMe-4; 6Þ2N2gðtmedaÞ
!
where M = Cd, Hg
Electronic spectra of these complexes in dichloromethane
showed single absorption band in the region 266–287 nm with a
shoulder at ꢃ304 nm only in mercury derivatives (3, 4). The ob-
served absorption can be assigned to ligand-to-ligand charge
transfer transition in the selenolate ligand.
2.2.7. Preparation of [HgCl{SeC4H(Me-4,6)2N2}(tmeda)] (7)
The 1H and 13C{1H} NMR spectra displayed expected reso-
nances. The CH-5 proton and carbon-13 resonance are shielded
in complexes with respect to the corresponding resonance for
the diselenides. Similarly CH-4,6 proton and carbon NMR reso-
nances of 1 and 3 are shielded. The 77Se NMR spectra exhibited a
single resonance in the region 214–342 ppm as expected for selen-
olate complexes. The resonance for Hg complex appeared at lower
field as compared to the corresponding signals for cadmium deriv-
atives (e.g., 77Se NMR d: 214 (1 Cd) versus 254 (3 Hg) ppm and 331
(2 Cd) versus 342 (4 Hg)). The 77Se NMR resonances for the chloro
complexes (6, 7) showed significant shielding with respect to the
corresponding bis derivatives (2 and 4) due to the presence of
chloro ligand. Both 113Cd{1H} and 199Hg{1H} NMR spectra showed
single resonances indicating the presence of a single molecular
Prepared in a similar fashion to 6 employing [Hg{SeC4H(Me-
4,6)2N2}2] (360 mg, 0.63 mmol), HgCl2 (171 mg, 0.63 mmol) and
tmeda (excess) and the resulting complex was recrystallized from
dichloromethane–hexane as colorless crystals (yield 561 mg, 83%),
m.p. 124 °C. Anal. Calc. for C12H23ClHgN4Se: C, 26.78; H, 4.31%.
Found: C, 27.01; H, 4.72%. UV–Vis kmax (CH2Cl2): 266 nm. 1H NMR
(CDCl3) d: 2.30 (s, Me); 2.44 (s, NMe2); 2.61 (s, NCH2–); 6.70 (ring
proton). 13C{1H} NMR (CDCl3) d: 23.6 (Me); 46.5 (NMe2); 56.8
(NCH2); 116.0 (CH-5); 166.5 (C-4,6); 171.2 (C-2) (ring carbons).
77Se{1H} NMR (CDCl3) d: 247. 199Hg{1H} NMR (CDCl3) d: ꢀ1218.
2.3. Preparation of metal selenide nanoparticles
To a pre-heated (250 °C) TOPO (3 g) in a three necked flask,
a
solution of [Cd{SeC4H(Me-4,6)2N2}2(tmeda)] (2) (100 mg,
Table 2
0.17 mmol) in OA (3 ml) was injected rapidly with vigorous stirring
under flowing argon (experiment 1). The temperature was dropped
to 220 °C, was raised to and maintained at 230 °C for 30 min. The
hot solution was cooled down rapidly to 70 °C and methanol
(20 ml) was added to get a reddish precipitate, which was washed
thoroughly with methanol, followed by centrifuging and drying
under vacuum. Red CdSe was extracted in toluene and evaporated
under vacuum. Similar experiment was also performed in OA
(experiment 2).
Similarly, [Hg{SeC4H(Me-4,6)2N2}2] (4) (90 mg, 0.16 mmol) was
pyrolysed in OA (3 ml)/OA (3 ml) (experiment 3) at 100 °C for
30 min and black precipitate was washed with methanol, followed
by centrifuging and drying under vacuum to give a black powder.
Selected bond lengths (Å) and angles (°) for [Cd{SeC4H(Me-4,6)2N2}2(tmeda)] (2).
Molecule a
Molecule b
Cd1–Se1
Cd1–N1
Cd1–N2
Se1–C4
2.6247(10)
2.428(7)
2.651(8)
1.907(9)
Cd2–Se2
Cd2–N4
Cd2–N5
Se2–C13
2.6123(10)
2.426(9)
2.672(9)
1.895(9)
Se1–Cd1–Se1i
Se1–Cd1–N1
Se1–Cd1–N1i
Se1–Cd1–N2
Se1–Cd1–N2i
Se1i–Cd1–N1
Se1i–Cd1–N1i
Se1i–Cd1–N2
Se1i–Cd1–N2i
N2–Cd1–N1
N2–Cd1–N1i
N2–Cd1–N2i
N1–Cd1–N2i
N2i –Cd1–N1i
N1–Cd1–N1i
140.15(6)
105.37(18)
105.88(19)
62.92(19)
95.99(18)
105.88(19)
105.37(18)
95.99(18)
62.92(18)
85.0(3)
Se2–Cd2–Se2ii
Se2–Cd2–N4
Se2–Cd2–N4ii
Se2–Cd2–N5
Se2–Cd2–N5ii
Se2ii–Cd2–N4
Se2ii–Cd2–N4ii
Se2ii–Cd2–N5
Se2ii–Cd2–N5ii
N5–Cd2–N4
139.81(6)
106.62(19)
104.9(2)
62.48(19)
96.27(19)
104.9(2)
106.62(19)
96.27(19)
62.49(19)
85.3(3)
3. Results and discussion
154.3(3)
118.0(4)
154.3(3)
85.0(3)
N5–Cd2–N4ii
N5ii–Cd2–N5
N4–Cd2–N5ii
N5ii–Cd2–N4ii
N4ii–Cd2–N4
153.2(3)
118.2(4)
153.2(3)
85.3(3)
3.1. Synthesis and spectroscopy
Treatment of [CdCl2(tmeda)] with two equivalents of sodium
salts of 2-pyrimidyl selenolate, NaSeC4H(R-4,6)2N2 (prepared
75.5(4)
75.6(4)